Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
Gezondheid en geneeskundeOne-Off1j
Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdHuidige gemeenschapsvoorspellingNee 81%
Voorspellers
7
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 2 uur geleden
Verouderd21 feb 23, 20:28 UTC31 dec 27, 22:59 UTC
Trends
Regels
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against pancreatic adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
